These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

168 related items for PubMed ID: 1789524

  • 1. Evaluation of a topically administered carbonic anhydrase inhibitor (MK-927) in normotensive and glaucomatous beagles.
    King TC, Gum GG, Gelatt KN.
    Am J Vet Res; 1991 Dec; 52(12):2067-70. PubMed ID: 1789524
    [Abstract] [Full Text] [Related]

  • 2. Changes in intraocular pressure associated with topical dorzolamide and oral methazolamide in glaucomatous dogs.
    Gelatt KN, MacKay EO.
    Vet Ophthalmol; 2001 Mar; 4(1):61-7. PubMed ID: 11397321
    [Abstract] [Full Text] [Related]

  • 3. Comparison of the effects of topical administration of a fixed combination of dorzolamide-timolol to monotherapy with timolol or dorzolamide on IOP, pupil size, and heart rate in glaucomatous dogs.
    Plummer CE, MacKay EO, Gelatt KN.
    Vet Ophthalmol; 2006 Mar; 9(4):245-9. PubMed ID: 16771760
    [Abstract] [Full Text] [Related]

  • 4. Ocular hypotensive effects of carbonic anhydrase inhibitors in normotensive and glaucomatous Beagles.
    Gelatt KN, Gum G, Williams LW, Gwin RM.
    Am J Vet Res; 1979 Mar; 40(3):334-45. PubMed ID: 475084
    [Abstract] [Full Text] [Related]

  • 5. Effect of topically applied demecarium bromide and echothiophate iodide on intraocular pressure and pupil size in beagles with normotensive eyes and beagles with inherited glaucoma.
    Gum GG, Gelatt KN, Gelatt JK, Jones R.
    Am J Vet Res; 1993 Feb; 54(2):287-93. PubMed ID: 8430939
    [Abstract] [Full Text] [Related]

  • 6. [Decrease in intraocular pressure following administration of the local carbonic anhydrase inhibitor (MK-927)--comparison of the effect with pilocarpine].
    Pfeiffer N, Grehn F, Hennekes R, Garus H.
    Fortschr Ophthalmol; 1990 Feb; 87(2):128-30. PubMed ID: 2192972
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. The effect of MK-927, a topical carbonic anhydrase inhibitor, on IOP in glaucomatous monkeys.
    Wang RF, Serle JB, Podos SM, Surgrue MF.
    Curr Eye Res; 1990 Feb; 9(2):163-8. PubMed ID: 2335112
    [Abstract] [Full Text] [Related]

  • 9. L-662,583 is a topically effective ocular hypotensive carbonic anhydrase inhibitor in experimental animals.
    Sugrue MF, Gautheron P, Mallorga P, Nolan TE, Graham SL, Schwam H, Shepard KL, Smith RL.
    Br J Pharmacol; 1990 Jan; 99(1):59-64. PubMed ID: 2110013
    [Abstract] [Full Text] [Related]

  • 10. Preclinical studies on L-671,152, a topically effective ocular hypotensive carbonic anhydrase inhibitor.
    Sugrue MF, Mallorga P, Schwam H, Baldwin JJ, Ponticello GS.
    Br J Pharmacol; 1989 Dec; 98 Suppl():820P. PubMed ID: 2611526
    [No Abstract] [Full Text] [Related]

  • 11. MK-927: a topically active ocular hypotensive carbonic anhydrase inhibitor.
    Sugrue MF, Gautheron P, Grove J, Mallorga P, Viader MP, Schwam H, Baldwin JJ, Christy ME, Ponticello GS.
    J Ocul Pharmacol; 1990 Dec; 6(1):9-22. PubMed ID: 2362161
    [Abstract] [Full Text] [Related]

  • 12. [A new topical carbonic anhydrase inhibitor (MK-927). Tolerance comparison with betaxolol in healthy probands].
    Feicht B, Hofmann HM, Lippa E, Brunner-Ferber F, von Denffer H, Merté HJ.
    Klin Monbl Augenheilkd; 1990 Sep; 197(3):254-7. PubMed ID: 2255169
    [Abstract] [Full Text] [Related]

  • 13. Methazolamide 1% in cyclodextrin solution lowers IOP in human ocular hypertension.
    Gudmundsdóttir E, Stefánsson E, Bjarnadóttir G, Sigurjónsdóttir JF, Gudmundsdóttir G, Masson M, Loftsson T.
    Invest Ophthalmol Vis Sci; 2000 Oct; 41(11):3552-4. PubMed ID: 11006251
    [Abstract] [Full Text] [Related]

  • 14. A comparison between the effect of topical and systemic carbonic anhydrase inhibitors on aqueous humor secretion.
    Brechue WF, Maren TH.
    Exp Eye Res; 1993 Jul; 57(1):67-78. PubMed ID: 8405174
    [Abstract] [Full Text] [Related]

  • 15. Switching from systemic to the topical carbonic anhydrase inhibitor dorzolamide: effect on the quality of life of glaucoma patients with drug-related side effects.
    Nesher R, Ticho U.
    Isr Med Assoc J; 2003 Apr; 5(4):260-3. PubMed ID: 14509130
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. The preclinical pharmacology of dorzolamide hydrochloride, a topical carbonic anhydrase inhibitor.
    Sugrue MF.
    J Ocul Pharmacol Ther; 1996 Apr; 12(3):363-76. PubMed ID: 8875343
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.